Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD4+CD45R+ cells are preferentially activated through the CD2 pathway.

T Matsuyama1, P Anderson, J F Daley

  • 1Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA.

European Journal of Immunology
|September 1, 1988
PubMed
Summary

CD4 cell subsets show distinct activation patterns. The CD4+CD45R+ subset preferentially activates via the CD2 pathway, suggesting differential activation contributes to CD4 cell functional diversity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-inflammatory Annexin A1 in Periodontitis via Formyl Peptide Receptor 2.

Journal of dental research·2025
Same author

[Clinical analysis of fertility-sparing therapy of patients with complex atypical hyperplasia and endometrial cancer].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2022
Same author

Clinical impacts of sun exposures on the faces and hands of Japanese women of different ages.

International journal of cosmetic science·2019
Same author

Hypoxia-inducible factor-1α inhibits interleukin-6 and -8 production in gingival epithelial cells during hypoxia.

Journal of periodontal research·2016
Same author

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma.

Leukemia·2015
Same author

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma.

British journal of cancer·2014

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • CD4+ T cell subsets, including CD4+CD45R+ (CDw29-) and CD4+CD45R- (CDw29+) cells, exhibit varied functions.
  • Understanding the differential activation of these subsets is crucial for comprehending immune responses.

Purpose of the Study:

  • To investigate the distinct activation pathways of CD4+CD45R+ and CD4+CD45R- cell subsets.
  • To determine the role of the CD3-Ti antigen-receptor complex and CD2 molecule in subset-specific activation.

Main Methods:

  • Utilized anti-CD3 antibodies to stimulate the CD3-Ti antigen-receptor complex.
  • Employed pairs of anti-CD2 antibodies (anti-T11(2) and anti-T11(3)) to activate the CD2 molecule.
  • Assessed cell activation in CD4+CD45R+ and CD4+CD45R- subsets in the presence of co-stimulatory signals like monocytes or interleukin-2.

Related Experiment Videos

Main Results:

  • CD4+CD45R+ cells demonstrated preferential activation through the CD2 pathway.
  • Both CD4+CD45R+ and CD4+CD45R- subsets showed equal activation via the CD3-Ti antigen-receptor pathway when co-stimulatory signals were present.
  • Differences in CD2 molecule responsiveness were not attributable to variations in T11(2) and T11(3) determinant expression.

Conclusions:

  • Differential activation of CD4 cell subsets through the CD2 molecule may contribute to their functional diversity.
  • These findings highlight distinct signaling mechanisms influencing CD4+ T cell subset behavior.